Murphy & Mullick Capital Management Corp Elanco Animal Health Inc Transaction History
Murphy & Mullick Capital Management Corp
- $135 Billion
- Q3 2025
A detailed history of Murphy & Mullick Capital Management Corp transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 500 shares of ELAN stock, worth $10,545. This represents 0.01% of its overall portfolio holdings.
Number of Shares
500Holding current value
$10,545% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
460Shares Held
491MCall Options Held
780KPut Options Held
1.08M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD31.5MShares$665 Million0.39% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...